SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000945621-23-000077
Filing Date
2023-02-13
Accepted
2023-02-13 12:19:46
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO SCHEDULE 13G carmignacclsd13ga4q2022.htm SC 13G/A 83606
  Complete submission text file 0000945621-23-000077.txt   85076
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Subject) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89527 | Film No.: 23616098
SIC: 2834 Pharmaceutical Preparations

Mailing Address 24 PLACE VENDOME PARIS I0 75001
Business Address 24 PLACE VENDOME PARIS I0 75001 0033142865335
Carmignac Gestion (Filed by) CIK: 0001569758 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A